Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Latest filing published 01 May 2026 for Merck & Co., Inc., €371k.
Filing timeline
BuySaleCaroline Litchfield
Insider track record
Disclosed buys
0
Disclosed sells
3
Signal history
Caroline Litchfield: trading record in brief
Caroline Litchfield made three open-market sales at Merck & Co., Inc., worth EUR 10.2 million: EUR 4,487,395 on February 14, 2024, EUR 4,251,186 on February 4, 2026 and EUR 1,436,399 on November 4, 2021. The median is EUR 4,251,186, and no purchase is on record.
The record holds 25 filings published between May 4, 2021 and May 1, 2026, all at Merck & Co., Inc. as chief financial officer ("EVP & CFO"). Beyond the sales, it consists of 12 grants and 10 option exercises.
The year 2021 is the busiest with 8 filings, followed by 5 in 2022 and in 2026; 2025 has just 1. Over the last 12 months, 5 filings were published, one of them a sale. Within 30 days of a trade by Caroline Litchfield, there are 2 trades by each of the colleagues at Merck & Co., Inc. named in the record, such as David Michael Williams or Dean Y. Li.
Companies and markets linked to Caroline Litchfield
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations25 total
3,935 shares@ US$110.030.0001% mcap3.4% of flowCommon StockSEC:0000310158-26-000082:0
1,938 shares@ US$110.030.0001% mcap1.7% of flowCommon StockSEC:0000310158-26-000082:1
41,997 shares@ US$119.6119.8% of flowCommon StockSEC:0000310158-26-000038:1
41,997 shares@ US$53.0617.1% of flowCommon StockSEC:0000310158-26-000038:0
15,852 shares@ US$107.4013.0% of flowCommon StockSEC:0000310158-26-000018:0
23,432 shares@ US$97.9419.9% of flowCommon StockSEC:0001127602-25-002349:0
38,291 shares@ US$125.5020.9% of flowCommon StockSEC:0001127602-24-005196:1
38,291 shares@ US$58.0818.8% of flowCommon StockSEC:0001127602-24-005196:0
19,208 shares@ US$119.4319.1% of flowCommon StockSEC:0001127602-24-002011:0
427 shares@ US$115.470.2% of flowCommon StockSEC:0001127602-23-014238:1
866 shares@ US$115.470.8% of flowCommon StockSEC:0001127602-23-014238:0
2,656 shares@ US$109.882.4% of flowCommon StockSEC:0001127602-23-002204:0
373 shares@ US$87.650.1% of flowCommon StockSEC:0001127602-22-013286:1
773 shares@ US$87.650.6% of flowCommon StockSEC:0001127602-22-013286:0
427 shares@ US$88.690.2% of flowCommon StockSEC:0001127602-22-013030:1
866 shares@ US$88.690.7% of flowCommon StockSEC:0001127602-22-013030:0
2,429 shares@ US$73.511.4% of flowCommon StockSEC:0001127602-22-007023:0
18,335 shares@ US$91.0011.4% of flowCommon StockSEC:0001127602-21-028467:1
22,683 shares0Common StockSEC:0001127602-21-028467:0
489 shares@ US$75.980.2% of flowCommon StockSEC:0001127602-21-015766:1
1,039 shares@ US$75.980.6% of flowCommon StockSEC:0001127602-21-015766:0
288 shares@ US$74.500.1% of flowCommon StockSEC:0001127602-21-015269:1
750 shares@ US$74.500.4% of flowCommon StockSEC:0001127602-21-015269:2
353 shares@ US$74.500.2% of flowCommon StockSEC:0001127602-21-015269:3
840 shares@ US$74.500.5% of flowCommon StockSEC:0001127602-21-015269:0
25 of 25 declarations
